In order to assess the potential importance of different cellular binding sites for the adverse effects of aminoglycosides (i.e. oto-and nephrotoxicity) the binding of neomycin and calcium to phospholipids and other anionic cell constituents was assayed in vitro. Phospholipids demonstrated binding affinities that strongly favored neomycin (Kin, 10 to 100 ,um) over calcium (Km, 300 to 1,120 ,um). Both neomycin and calcium showed strongest binding to lipids with monoester phosphate groups: phosphatidic acid, phosphatidylinositol 4-phosphate, and phosphatidylinositol 4,5-bisphosphate.
glycosides. Furthermore, if one considers extra-and intracellular calcium and neomycin concentrations, the relative affinity of lipids for these two compounds suggests an explanation for both the reversible and the essentially irreversible toxic effects of the aminoglycosides.
The ototoxicity of aminoglycoside antibiotics is well documented and a rational hypothesis of their action has been proposed.1,2) However, some details of this mechanism have yet to be fully described.
There is evidence that a major component of the actions of these drugs is exerted at the cell membrane. Acute effects on the microphonic potential of the cochlea3) and the lateral line organ4) are rapidly reversed by the addition of competing cations indicative of a plasma membrane action.
Chronic toxicity has also been linked to an interference with the metabolism and function of membrane lipids, in particular, of the polyphosphoinositides. For example, the aminoglycoside neomycin, has been shown to inhibit labeling of phosphatidylinositol 4,5-bisphosphate (PtdInsP2) in vivo and to prevent enzymatic hydrolysis of polyphosphoinositides in vitro.5,6) Furthermore, a strong correlation exists between the degree of ototoxicity of the aminoglycosides and their ability to disrupt the structure of artificial phosphoinositide membranes. 7, 8) While the polyphosphoinositides appear to be a major intracellular site of aminoglycoside action, these drugs also bind to other lipids and anionic cell components.8~11) The contribution of these interactions to acute and chronic toxicity has not yet been systematically assessed. This study aims to determine the relative binding affinity of neomycin and calcium, the major cation of excitable membranes, for various phospholipids and other macromolecules in order to gain more insight into potential cellular binding sites for aminoglycosides.
Materials and Methods
Phosphatidyl serine (PtdSer), phosphatidylinositol (Ptdlns), phosphatidic acid (Ptd), phosphatidyl glycerol (PtdGro) and cardiolipin were purchased from Sigma Chemical Co. (St. Louis, MO). Phosphatidylinositol 4-phosphate (PtdInsP) and phosphatidylinositol 4,5-bisphosphate (PtdInsP2) were isolated from Sigma phosphoinositides (catalogue no. P6023) by chromatography on immobilized neomycin.12) The purity of the lipids was greater than 95% as determined by thin-layer chromatography.
Radioactive calcium was purchased from NEN, Boston, MA.
[14C]Neomycin was a gift from Dr. GORDON FLYNN, The University of Michigan.
Methods
Lipid-bound calcium and neomycin were determined in a biphasic chloroform -water system with a final volume of 0.20 ml in each phase. In both assays the lipid phase contained 0.1 mm lipid in chloroform. Lipid concentrations were determined by assay of lipid phosphorus. 13) Calcium Binding: The aqueous phase contained 187 mm NaCl, 10 mivt sodium N-2-hydroxyethylpiperazine N-2-ethanesulfonic acid (HEPES), pH 7.4, and 45Ca++ in concentrations of 0.1 to 1 mm (0.1 1Ci).
Neomycin Binding: The aqueous phase contained [14C]neomycin in NaCl -HEPES as above to a final concentration of 0.1 to I mm (specific radioactivity 1.35 mCi/mmol).
The phases were mixed for 30 seconds and separated by centrifugation for 15 minutes at 2,000 rpm. The aqueous layer was removed and radioactivity in the lipid phase, indicative of bound calcium or neomycin, was determined by liquid scintillation counting. Blanks contained all components of the assay except the lipid. Radioactivity in these blanks did not significantly exceed background counts.
Competition Studies: CaCl2 was added to the [14C]neomycin-containing aqueous phase to a final concentration of 1 to 10 mm. Conversely, 0.1 to 1 mm neomycin were added to the "Ca-assays.
Displacement Studies: [14C]Neomycin was bound to lipid as described above and the lipid layer was used in the displacement assay. The lipid phase was repartitioned with 200 Id of a newly added aqueous phase containing 1 to 10 mm of the competitor in NaCl -HEPES buffer. The phases were mixed, centrifuged and aliquots were taken from the aqueous layer for determination of displaced [14C]neomycin.
Calculations: Michaelis-Menton constants (Kin) were calculated either from Lineweaver-Burke or Scatchard plots based on least squares analysis. The number of binding sites was quantitated form Scatchard plots.14)
Results

Neomycin Binding
Neomycin bound strongly to all of the phospholipids tested with binding affinities (expressed as Km) in the range of 10 to 100 /tM ( Table 1) 
Calcium Binding
As with neomycin, the lipids Ptd, PtdInsP and PtdInsP2 demonstrated the strongest affinity for calcium, followed by PtdSer, cardiolipin and Ptdlns (Table 2) ,nM and 53.+36 /IM respectively.
Competition Between Lipids and Non-lipid Compounds for Neomycin
The ability of anionic non-lipid compounds to compete for neomycin bound to a phospholipid was studied in "displacement" assays. The compounds tested were cellular components with a reported ability to bind aminoglycosides (melanin11) and the mucopolysaccharide chondroitin sulfate10)) or calcium (gangliosides15)).
The assay was based on the assumption that 50% of the bound neomycin would be displaced from the lipid if the tested molecule had an equal affinity for neomycin and was added in equimolar amounts to the lipid.
Chondroitin sulfate, gangliosides and melanin all were inefficient competitors. The displacement was dose dependent, but at 1 mm, i.e. at a 10-fold higher concentration than the lipid, only 5 % of the bound neomycin was displaced from PtdSer ( Fig. 2) . Even at concentrations of fifty times that of the lipid, a maximum of 13 % of the neomycin was displaced.
Discussion
All phospholipids tested in this study showed binding affinities up to fifty-fold stronger for neomycin than for calcium as seen in the individual binding constants (Km). This was further supported PtdSer and Ptdlns showed widely varied affinities. The determining factor for high binding affinity for both calcium and neomycin thus seems to be the presence of monoester phosphate groups.
The rank-order of affinities of the various lipids for calcium measured in this biphasic system agrees well with those extrapolated from calcium adsorption to PtdlnsP2, Ptd and PtdSer in monolayers.16) Although the total number of phosphate groups is not a factor in the affinity of the binding, these sites do determine the number of calcium molecules bound by the lipid. Lipids with potentially three (PtdlnsP and cardiolipin) and five (PtdlnsP2) negative charges bind more calcium molecules, but this correlation did not hold for neomycin binding.
Here, steric hindrance caused by the large size of the neomycin molecule may be an additional determining factor.17)
While all phospholipids have a high affinity for neomycin, the other anionic compounds tested were inefficient in their competition for the drug.
Neither melanin, chondroitin sulfate nor gangliosides were able to displace significant amounts of neomycin from lipid. Extrapolations from the in vitro to the in vivo situation have to be made with caution but it should be emphasized that the binding data were obtained at a pH and a concentration of monovalent cations that resemble physiological conditions. Thus, the results strongly indicate that phospholipids will be preferred cellular drug binding sites and that melanin, mucopolysaccharides and gangliosides are less important in the toxic actions of aminoglycosides. The differences in affinity of the various lipids to neomycin do not seem significant enough to explain that this drug specifically affects the metabolism of phosphoinositides in vivo and in vitro.1,5,6) However, if we consider the asymmetric lipid distribution of natural membranes as well as the differences in extra-and intracellular calcium concentrations an explanation becomes apparent. Since polyphosphoinositides are thought to be present on the cytoplasmic side of the plasma membrane, they would not be the first target of the drug in its interaction with the cell. The drug would first bind to an anionic site on the outer membrane leaflet, probably PtdSer, PtdGro, or PtdIns.
This binding is in competition with extracellular calcium, the concentration of which is well in the range of the Ki of calcium inhibition of lipid-neomycin binding. Thus, any acute drug toxicity based on calcium displacement may easily be reversed. Next, the drug is transported across the membrane in an energydependent process. 2) Once inside the cell, the drug would bind preferentially to a polyphosphoinositide or phosphatidic acid. From pharmacokinetic studies") we can estimate the intracellular aminoglycoside concentration to reach 10 to 100 /IM in the inner ear tissues while the intracellular calcium concentration is in the low micromolar range. Given the fifty-fold difference in binding affinities, neomycin would effectively and essentially irreversibly displace calcium from these lipids.
The resultant inhibition of polyphosphoinositide metabolism5) and disturbance of membrane integrity would then account for further toxic effects of aminoglycosides.1) It is important to note that phosphatidylinositol 4,5-bisphosphate has recently been implicated as a physiologically important lipid constituting a second messenger system for hormone actions that regulate cell processes via the mobilization of intracellular calcium. 19, 20) In conclusion, the results emphasize the importance of phospholipids as cellular binding sites for aminoglycosides.
Furthermore, the comparison of the relative affinities for calcium and for neomycin under consideration of extra-and intracellular calcium concentrations suggest an explanation for the reversible and for the essentially irreversible effects of the antibiotics. THE JOURNAL OF ANTIBIOTICS MAR.
